# A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

> **NCT07117279** · — · NOT_YET_RECRUITING · sponsor: **Tongji Hospital** · enrollment: 120 (estimated)

## Conditions studied

- HCC - Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07117279
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07117279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07117279, "A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT07117279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*